%0 Journal Article
%T The battle between host antiviral innate immunity and immune evasion by cytomegalovirus.
%A Li S
%A Xie Y
%A Yu C
%A Zheng C
%A Xu Z
%J Cell Mol Life Sci
%V 81
%N 1
%D 2024 Aug 9
%M 39120730
%F 9.207
%R 10.1007/s00018-024-05369-y
%X Cytomegalovirus (CMV) has successfully established a long-lasting latent infection in humans due to its ability to counteract the host antiviral innate immune response. During coevolution with the host, the virus has evolved various evasion techniques to evade the host's innate immune surveillance. At present, there is still no vaccine available for the prevention and treatment of CMV infection, and the interaction between CMV infection and host antiviral innate immunity is still not well understood. However, ongoing studies will offer new insights into how to treat and prevent CMV infection and its related diseases. Here, we update recent studies on how CMV evades antiviral innate immunity, with a focus on how CMV proteins target and disrupt critical adaptors of antiviral innate immune signaling pathways. This review also discusses some classic intrinsic cellular defences that are crucial to the fight against viral invasion. A comprehensive review of the evasion mechanisms of antiviral innate immunity by CMV will help investigators identify new therapeutic targets and develop vaccines against CMV infection.